CERo Therapeutics Holdings (CERO) Ownership - Who Owns CERo Therapeutics Holdings?
CERo Therapeutics Holdings (CERO) Ownership Overview
- 9.11% Insiders
- 0.03% Other Institutional Investors
- 90.86% Public Companies and Individual Investors
The ownership structure of CERo Therapeutics Holdings (CERO) stock is a mix of institutional, retail, and individual investors. Approximately 0.03% of the company’s stock is owned by Institutional Investors, 9.11% is owned by Insiders, and 90.86% is owned by Public Companies and Individual Investors.
The ownership structure of CERo Therapeutics Holdings (CERO) stock is a mix of institutional, retail, and individual investors. Approximately 0.03% of the company’s stock is owned by Institutional Investors, 9.11% is owned by Insiders, and 90.86% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Christopher Ehrlich | 5,795,408 | Insider | 7.27% | 57,954 |
| Kathleen Laporte | 971,825 | Insider | 1.22% | 9,718 |
| Brian Atwood | 491,784 | Insider | 0.62% | 4,918 |
FAQ
Who Owns CERo Therapeutics Holdings (CERO)?
According to the latest TipRanks data, approximately 0.03% of the company's stock is held by institutional investors, 9.11% is held by insiders, and 90.86% is held by public companies and individual investors.
What percentage of CERo Therapeutics Holdings (CERO) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.03% of CERo Therapeutics Holdings (CERO) stock is held by institutional investors.
What percentage of CERo Therapeutics Holdings (CERO) stock is held by retail investors?
According to the latest TipRanks data, approximately 90.86% of CERo Therapeutics Holdings (CERO) stock is held by public companies and individual investors.
Who owns the most shares of CERo Therapeutics Holdings (CERO)?
Christopher Ehrlich owns the most shares of CERo Therapeutics Holdings (CERO).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
